Literature DB >> 3722409

Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles.

G Uko, F T Christiansen, R L Dawkins, V J McCann.   

Abstract

Serum C4 concentrations were measured in 102 healthy subjects and 90 subjects with type I diabetes mellitus. A wide range was observed in the group as a whole (0.08-0.67 g/l; mean = 0.26 g/l; SEM = 0.01 g/l). After C4 allotyping it was possible to subgroup 134 of these subjects according to the number of C4 null alleles present. C4 concentrations in the group with two null alleles were lower than in the group without null alleles (mean 0.2 v 0.37 g/l; p less than 0.001). C4 concentrations in the group with one C4 null allele were intermediate and significantly different from those of the group without null alleles (mean 0.24 v 0.37 g/l; p less than 0.001). Appropriate analysis has defined reference ranges for serum C4 concentrations in subjects with two, one, or zero C4 null alleles. Interpretation of low serum C4 concentrations should take account of the number of C4 null alleles present.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722409      PMCID: PMC499922          DOI: 10.1136/jcp.39.5.573

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  Two HLA-linked loci controlling the fourth component of human complement.

Authors:  G J O'Neill; S Y Yang; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Neutralization of sensitized virus by purified components of complement.

Authors:  C A Daniels; T Borsos; H J Rapp; R Snyderman; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1970-03       Impact factor: 11.205

3.  Distribution of HLA A, B and C antigens in an Australian population.

Authors:  B R Hawkins; J B Houliston; R L Dawkins
Journal:  Hum Genet       Date:  1979-11       Impact factor: 4.132

4.  Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis.

Authors:  D Vergani; L Wells; V F Larcher; B A Nasaruddin; E T Davies; G Mieli-Vergani; A P Mowat
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

5.  HLA, anti-DNA, and complement in myasthenia gravis.

Authors:  F T Christiansen; J B Houliston; R L Dawkins
Journal:  Muscle Nerve       Date:  1978 Nov-Dec       Impact factor: 3.217

6.  The C4 system: quantitative studies of different genotypes.

Authors:  B Olaisen; P Teisberg; R Jonassen
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

7.  Genetic analysis of C4 deficiency.

Authors:  Z L Awdeh; H D Ochs; C A Alper
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

8.  HLA in systemic lupus erythematosus: influence on severity.

Authors:  R J Rigby; R L Dawkins; J D Wetherall; B R Hawkins
Journal:  Tissue Antigens       Date:  1978-07

9.  BF types and the mode of inheritance of insulin-dependent diabetes mellitus (IDDM).

Authors:  D Raum; Z Awdeh; C A Alper
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

10.  Inherited structural polymorphism of the fourth component of human complement.

Authors:  Z L Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  10 in total

1.  Effects of C4 null alleles and homoduplications on quantitative expression of C4A and C4B.

Authors:  A Hammond; W Ollier; M J Walport
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

2.  Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.

Authors:  J A Charlesworth; P W Peake; J Golding; J D Mackie; B A Pussell; V Timmermans; D Wakefield
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

3.  DNase I hypersensitivity mapping and promoter polymorphism analysis of human C4.

Authors:  A K Vaishnaw; R Hargreaves; R D Campbell; B J Morley; M J Walport
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

4.  Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins.

Authors:  Erwin K Chung; Yan Yang; Kristi L Rupert; Karla N Jones; Robert M Rennebohm; Carol A Blanchong; C Yung Yu
Journal:  Am J Hum Genet       Date:  2002-09-10       Impact factor: 11.025

5.  Serum C4 concentration in the monitoring of systemic lupus erythematosus: requirement for C4 allotyping.

Authors:  G Uko; F T Christiansen; R L Dawkins
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

6.  The complement system in type 1 (insulin-dependent) diabetes.

Authors:  J A Charlesworth; V Timmermans; J Golding; L V Campbell; P W Peake; B A Pussell; D Wakefield; N Howard
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

7.  Influence of C4 null genes on infection with human immunodeficiency virus.

Authors:  P U Cameron; T J Cobain; W J Zhang; P H Kay; R L Dawkins
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-11

8.  Mannose binding lectin (MBL) copy number polymorphism in Zebrafish (D. rerio) and identification of haplotypes resistant to L. anguillarum.

Authors:  Andrew N Jackson; Craig A McLure; Roger L Dawkins; Peter J Keating
Journal:  Immunogenetics       Date:  2007-10-18       Impact factor: 2.846

9.  C4 concentrations and C4 deficiency alleles in systemic lupus erythematosus.

Authors:  W A Wilson; P E Armatis; M C Perez
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103

10.  Conservation of the central MHC genome: PFGE mapping and RFLP analysis of complement, HSP70, and TNF genes in the goat.

Authors:  P U Cameron; H A Tabarias; B Pulendran; W Robinson; R L Dawkins
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.